

Zinnat - an antibacterial drug from the group of aminoglycosides for local use in ENT practice
Active against gram-positive and gram-negative bacteria that cause the development of infectious processes in the upper respiratory tract.
As part of combination therapy in infectious and inflammatory diseases of the upper respiratory tract, including: rhinitis; rhinopharyngitis; sinusitis (with no damage to the septum).
Prevention and treatment of inflammatory processes after surgery.
Hypersensitivity to framycetin and other aminoglycoside antibiotics;
pregnancy and lactation.
Adults appoint 1 injection in each nostril 4-6 times a day.
Children - 1 injection in each nostril 3 times a day.
The average duration is 7 days.
When used, the bottle should be kept upright.
Allergic reactions.
If within 7 days of treatment the therapeutic effect is absent or weakly expressed, the drug Isofra should be discontinued.
Store at a temperature not higher than 25 ° С.
- 3 years.
Isofra